NSC |
Compound |
Enrichment |
Correlation |
NSC 59220 |
[[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt |
0.0209467683758286 |
0.13396798 |
NSC 610458 |
Camptothecin Derivative |
0.0209467683758286 |
0.11584152 |
NSC 610459 |
Camptothecin Derivative |
0.0209467683758286 |
0.026879116 |
NSC 611377 |
Null |
0.0209467683758286 |
0.40531395 |
NSC 620277 |
4-N,N-bis-2'-cyanoethylaminobenzylidene-4-fluoro aniline |
0.0209467683758286 |
0.15825779 |
NSC 624233 |
Null |
0.0209467683758286 |
0.37312826 |
NSC 632882 |
Dicarbonyl[1-(4-cyanaphenyl-NC-azomethyine)- naphthaline-2-olato(O1,N1)]iridium(I) |
0.0209467683758286 |
0.74288606 |
NSC 637467 |
Disulfide, bis[2-amino-4-(4-methoxyphenyl)-1-methyl- 1H-imidazol-5-yl], dihydrochloride |
0.0209467683758286 |
0.38594721 |
NSC 639174 |
Camptothecin Derivative |
0.0209467683758286 |
0.12906022 |
NSC 639186 |
Raltitrexed |
0.0209467683758286 |
0.066501884 |